Campbell & Co. Investment Adviser »

Fulcrum Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $943k 103k 9.20

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics